For the Inventor, By the Inventor

Enter assignee name

Franklin, TN, United States of America

Biomimetic Therapeutics, LLC

USPTO Granted Patents = 23

CIPO Patents = 21

EPO Patents = 14

Trademarks = 2

Forward Citations = 156

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Samuel E Lynch (19 out of 23 patents)

Charles E Hart (10 out of 52 patents)

Hans K Kestler (7 out of 7 patents)

4. Vivek Shah (4 out of 4 patents)

5. Dean James Rager-Aguiar (4 out of 6 patents)

6. Conan S Young (4 out of 4 patents)

7. Leslie Wisner-Lynch (3 out of 6 patents)

8. Yanchun Liu (3 out of 8 patents)

9. Dan Perrien (2 out of 2 patents)

10. Michael G Ehrlich (2 out of 5 patents)

11. Joshua Nickols (2 out of 2 patents)

12. Jeffrey O Hollinger (2 out of 11 patents)

13. Douglas C Moore (2 out of 3 patents)

14. Myron Nevins (1 out of 1 patent)

15. Massimo Simion (1 out of 1 patent)

23 patents: Sort by Forward Citations

1. 11571497 - Platelet-derived growth factor compositions and methods of use thereof (2023-02-07),

2. 11364325 - Platelet-derived growth factor compositions and methods of use thereof (2022-06-21),

3. 11318230 - Platelet-derived growth factor compositions and methods of use thereof (2022-05-03),

4. 11235030 - Platelet-derived growth factor compositions and methods for the treatment of tendinopathies (2022-02-01),

5. 11135341 - Platelet-derived growth factor composition and methods for the treatment of tendon and ligament injuries (2021-10-05),

6. 11058801 - Compositions and methods for treating the vertebral column (2021-07-13),

7. 10556039 - Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries (2020-02-11),

8. 10493130 - Platelet-derived growth factor compositions and methods for the treatment of tendinopathies (2019-12-03),

9. 10456450 - Compositions and methods for treating rotator cuff injuries (2019-10-29),

10. 10258566 - Compositions and methods for treating bone (2019-04-16),

11. 9642892 - Platelet-derived growth factor compositions and methods for the treatment of tendinopathies (2017-05-09),

12. 9642891 - Compositions and methods for treating rotator cuff injuries (2017-05-09),

13. 9545377 - Platelet-derived growth factor compositions and methods of use thereof (2017-01-17),

14. 9161967 - Compositions and methods for treating the vertebral column (2015-10-20),

15. 8870954 - Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries (2014-10-28),

Company Overview

Biomimetic Therapeutics, LLC is a biotechnology company based in Franklin, TN, specializing in the development of innovative therapeutic solutions inspired by biological processes. The organization focuses on creating advanced medical treatments that leverage biomimetic principles to enhance healing and recovery. Its research spans various domains, including regenerative medicine and tissue engineering, aiming to address complex medical challenges through cutting-edge technology and scientific exploration.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

23 Patents

#13 in Franklin, TN

#142 in Tennessee

#14,438 in US

#27,714 in the World

Franklin, TN, United States of America

Biomimetic Therapeutics, LLC

Forward Citations = 156

16 inventors:

Samuel E Lynch (19 out of 23 patents)

Charles E Hart (10 out of 52 patents)

Hans K Kestler (7 out of 7 patents)

4. Vivek Shah (4 out of 4 patents)

5. Dean James Rager-Aguiar (4 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biomimetic Therapeutics, LLC. Retrieved from https://idiyas.com/company/biomimetic-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…